Vascular Endothelial Growth Factor Inhibitor class drugs

1 result

Byooviz (ranibizumab-nuna)

(ranibizumab-nuna)
BIOGEN INC.
Usage: BYOOVIZ is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).